Insight Advisors LLC PA Purchases 56,776 Shares of Kenvue Inc. $KVUE

Insight Advisors LLC PA purchased a new stake in Kenvue Inc. (NYSE:KVUE) in the third quarter, HoldingsChannel reports. The institutional investor purchased 56,776 shares of the company’s stock, valued at approximately $1,003,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Johnson Financial Group Inc. acquired a new position in Kenvue in the second quarter valued at $26,000. CoreCap Advisors LLC increased its position in shares of Kenvue by 64.9% during the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock worth $29,000 after purchasing an additional 591 shares in the last quarter. GK Wealth Management LLC acquired a new stake in shares of Kenvue during the third quarter worth about $27,000. Bell Investment Advisors Inc purchased a new stake in shares of Kenvue in the 2nd quarter valued at about $35,000. Finally, Keating Financial Advisory Services Inc. purchased a new stake in shares of Kenvue in the 2nd quarter valued at about $38,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Up 4.4%

KVUE opened at $19.89 on Friday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $20.13. The business has a 50 day moving average price of $18.34 and a two-hundred day moving average price of $18.26. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. The company has a market cap of $38.19 billion, a PE ratio of 22.86, a P/E/G ratio of 1.74 and a beta of 0.48.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). The company had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.29 earnings per share. As a group, research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 2nd. Investors of record on Monday, September 21st were issued a dividend of $0.21 per share. The ex-dividend date of this dividend was Monday, September 21st. This represents a $0.84 annualized dividend and a dividend yield of 4.2%. Kenvue’s dividend payout ratio (DPR) is currently 96.55%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on KVUE. Weiss Ratings reissued a “hold (c)” rating on shares of Kenvue in a research report on Friday, September 11th. Barclays raised their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. UBS Group decreased their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Tuesday, August 11th. Finally, Wall Street Zen lowered shares of Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Ten investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $18.43.

About Kenvue

Kenvue Inc is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels.

The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson’s and OGX in oral care, baby care and hair care.